Revolution Medicines, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $92.7M | $567.4M | $104.3M |
| FY2021 | $135.4M | $738.0M | $108.5M |
| FY2022 | $126.7M | $811.9M | $161.4M |
| FY2023 | $235.5M | $2.06B | $696.1M |
| FY2024 | $293.1M | $2.56B | $543.1M |